{
    "symbol": "SAGE",
    "quarter": 3,
    "year": 2022,
    "date": "2022-11-08 14:38:17",
    "content": " Specifically, the SHORELINE Study demonstrated that among patients with MDD, who responded to the initial two week treatment with zuranolone 80% received one or two 14-day treatment courses during their time in the study were patients had the opportunity to be followed up for a year. As it relates to the potential durability of zuranolone for patients with PPD data from the SKYLARK Study demonstrated positive results across all primary and secondary endpoints, including statistically significant responses across all time periods measure, which further highlights durability. Your line is open. Your line is open. It's also informative to understand when we treat somebody with two weeks course of treatment, the durability of the effect, you're on the call that for those that respond to the first treatment of SHORELINE, majority required only one or two, three courses of year and meeting times or treatments 249 days really speaking to the durability of effect. Your line is open. Your line is open. Your line is open. Your line is open. Yes, let me -- I'll just add that when we look at the human clinical trials, such as SHORELINE largest not SHORELINE study ever run in depression, and we've heard these data, the majority of patients that responded record on a two week course of treatment and an 80% required one or two week course of treatment. Your line is open."
}